(2 of 2)
Rosenberg has also been criticized for inflating patients' hopes by publicizing his experiment before there are any results to report. "It's a very high-profile research activity that Steve Rosenberg is running," Dr. Philip Leder of Harvard University School of Medicine told the New York Times. "He didn't come to you after the experiment was successful. He came at the beginning, because it might be quite uninteresting when it's all finished." Given all the attention and elevated hopes, Rosenberg should reveal his results -- even if they are uninteresting -- with the same alacrity he shows in announcing the start of an experiment.